Report of Foreign Issuer (6-k)
September 12 2017 - 4:58PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
Report
of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934
September 12, 2017
PROQR THERAPEUTICS N.V.
Zernikedreef 9
2333 CK
Leiden
The Netherlands
Tel: +31 88 166 7000
(Address, Including ZIP Code, and Telephone Number,
Including Area Code, of Registrants Principal Executive Offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
On September 12,
2017, ProQR Therapeutics N.V. (the
Company
) issued a press release titled, ProQR spins out Amylon Therapeutics as a privately-held company focused on central nervous system (CNS) therapeutics. A copy of this press
release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. The Company hereby incorporates by reference the information contained herein into the Companys registration statement on Form F-3 (File No. 333-207245).
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
PROQR THERAPEUTICS N.V.
|
|
|
|
|
Date: September 12, 2017
|
|
|
|
By:
|
|
/s/ Smital Shah
|
|
|
|
|
|
|
Smital Shah
Chief Financial
Officer
|
INDEX TO EXHIBITS
|
|
|
Number
|
|
Description
|
|
|
99.1
|
|
ProQR spins out Amylon Therapeutics as a privately-held company focused on central nervous system (CNS) therapeutics.
|
ProQR Therapeutics NV (NASDAQ:PRQR)
Historical Stock Chart
From Apr 2024 to May 2024
ProQR Therapeutics NV (NASDAQ:PRQR)
Historical Stock Chart
From May 2023 to May 2024